Track Biotechnology Master Fund, Ltd. Deep, a 10% owner of $DVAX, sold 1,094,994 shares of the company on 08-21-2025 for an estimated $12,077,783. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.2% of their shares of this class of stock. Following this trade, they now own 16,696,492 shares of this class of $DVAX stock.
$DVAX Insider Trading Activity
$DVAX insiders have traded $DVAX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $DVAX stock by insiders over the last 6 months:
- TRACK BIOTECHNOLOGY MASTER FUND, LTD. DEEP has made 0 purchases and 2 sales selling 2,065,137 shares for an estimated $22,351,598.
- DAVID F NOVACK (President & COO) has made 0 purchases and 3 sales selling 56,784 shares for an estimated $801,865.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DVAX Hedge Fund Activity
We have seen 106 institutional investors add shares of $DVAX stock to their portfolio, and 192 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC removed 3,800,500 shares (-66.1%) from their portfolio in Q2 2025, for an estimated $37,700,960
- BLACKROCK, INC. removed 3,047,193 shares (-15.0%) from their portfolio in Q2 2025, for an estimated $30,228,154
- MILLENNIUM MANAGEMENT LLC added 1,386,541 shares (+612.1%) to their portfolio in Q2 2025, for an estimated $13,754,486
- INVESCO LTD. removed 1,221,651 shares (-55.3%) from their portfolio in Q2 2025, for an estimated $12,118,777
- EVERSEPT PARTNERS, LP added 1,197,189 shares (+inf%) to their portfolio in Q2 2025, for an estimated $11,876,114
- D. E. SHAW & CO., INC. removed 1,062,388 shares (-42.7%) from their portfolio in Q2 2025, for an estimated $10,538,888
- TWO SIGMA ADVISERS, LP added 1,019,800 shares (+110.7%) to their portfolio in Q2 2025, for an estimated $10,116,416
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DVAX Analyst Ratings
Wall Street analysts have issued reports on $DVAX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 08/08/2025
- Goldman Sachs issued a "Sell" rating on 04/17/2025
To track analyst ratings and price targets for $DVAX, check out Quiver Quantitative's $DVAX forecast page.
$DVAX Price Targets
Multiple analysts have issued price targets for $DVAX recently. We have seen 2 analysts offer price targets for $DVAX in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Roy Buchanan from JMP Securities set a target price of $32.0 on 08/22/2025
- Paul Choi from Goldman Sachs set a target price of $10.0 on 04/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
